Occidental Petroleum (NYSE: OXY) is one of the largest US-focused integrated oil & gas producers, headquartered in Houston, Texas. The company operates three segments: Oil and Gas (exploration and production in the Permian Basin, DJ Basin, Gulf of Mexico, plus international operations in the Middle East, North Africa, and Latin America), Chemical (OxyChem) (chlorine, caustic soda, vinyls, and specialty chemicals), and Midstream & Marketing (gathering, processing, transportation, storage, plus carbon dioxide for EOR). Founded 1920; IPO 1981 (current listing).
The investment narrative is anchored on three pillars: (1) Permian Basin operational excellence under CEO Vicki Hollub — well costs, recovery rates, and breakeven economics among the best in the industry; (2) aggressive deleveraging following the 2019 Anadarko acquisition and 2024 CrownRock acquisition — long-term debt reduced to $13.3B; (3) the famous Berkshire Hathaway position (~28% economic stake including warrants), which provides both governance support and a perpetual partial-acquisition speculation overhang.
Reports financials in USD. FY2025 revenue: $21.6B; net income $2.4B; FCF $4.1B (positive). Q1 2026 results reported May 5: EPS $1.06 beat consensus by 63%. Today's -7% selloff reflects two cross-currents: (a) potential US-Iran diplomatic resolution reducing the Strait of Hormuz war premium, and (b) negative reported FCF in Q1 driven by working capital headwinds (per Seeking Alpha "Time to Take Profits" downgrade today).
Investment Thesis
OXY is a quality Permian operator with embedded optionality from the Berkshire stake and a structurally improving balance sheet. At $55.12, the stock trades at 6x FY2026E EBITDA and yields ~4% — reasonable for the asset base but no longer cheap.
Bull drivers: Q1 2026 production beat guidance; well-cost reductions continuing under new President & CFO transitions (Richard Jackson promotion). OxyChem segment provides ~$1B annual EBITDA cushion against oil price volatility. Continued deleveraging — long-term debt down from $28.9B (FY21) to $20.4B (FY25); will retire Berkshire preferred ($8.3B) when financially possible. 1Y consensus PT $73.50 (last month, +33% upside) reflects sell-side optimism on Permian execution.
Key risks: Today's -7% selloff highlights the thesis fragility — much of OXY's recent strength came from elevated oil prices driven by Iran/Hormuz tension. A diplomatic resolution would compress the geopolitical premium across the energy complex. Q1 2026 reported negative free cash flow (working capital drag); FY26 guided FCF requires WTI ≥$65 to fully fund the dividend and buyback. Berkshire warrants ($59 strike on 83.9M shares) cap upside near current levels — a structural ceiling. CEO Hollub announced operational responsibility hand-off to Richard Jackson in March 2026 — leadership transition risk.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $25.96B | $36.25B | $28.33B | $27.10B | $21.59B |
| Revenue Growth | — | +39.6% | -21.9% | -4.4% | -20.3% |
| Gross Profit | $7.60B | $17.05B | $9.74B | $9.65B | $7.29B |
| Gross Margin | 29.3% | 47.0% | 34.4% | 35.6% | 33.8% |
| Operating Income | $4.67B | $13.28B | $6.49B | $5.97B | $3.72B |
| Operating Margin | 18.0% | 36.6% | 22.9% | 22.0% | 17.2% |
| EBITDA | $13.89B | $22.16B | $14.54B | $12.72B | $11.36B |
| Net Income | $2.31B | $13.22B | $4.67B | $3.04B | $2.37B |
| EPS (Diluted) | $1.58 | $12.40 | $3.90 | $2.44 | $1.61 |
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & ST Investments | $2.76B | $0.98B | $1.43B | $2.13B | $1.99B |
| Total Assets | $75.04B | $72.61B | $74.01B | $85.45B | $86.78B |
| PP&E (Net) | $60.66B | $59.29B | $59.66B | $70.32B | $64.55B |
| Total Debt | $30.39B | $20.77B | $20.91B | $27.10B | $23.96B |
| Net Debt | $27.62B | $19.78B | $19.49B | $24.97B | $21.97B |
| Stockholders' Equity | $20.33B | $30.09B | $30.25B | $34.16B | $36.03B |
| Berkshire Preferred | $9.76B | $9.76B | $8.29B | $8.29B | $8.29B |
| Current Ratio | 1.23x | 1.15x | 0.92x | 0.95x | 0.94x |
| Net Debt/EBITDA | 1.99x | 0.89x | 1.34x | 1.96x | 1.93x |
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $10.43B | $16.81B | $12.31B | $11.44B | $10.53B |
| OCF Margin | 40.2% | 46.4% | 43.4% | 42.2% | 48.8% |
| Capital Expenditures | -$2.87B | -$4.50B | -$6.27B | -$7.02B | -$6.43B |
| CapEx % of Rev | 11.1% | 12.4% | 22.1% | 25.9% | 29.8% |
| Free Cash Flow | $7.56B | $12.46B | $6.06B | $4.42B | $4.11B |
| FCF Margin | 29.1% | 34.4% | 21.4% | 16.3% | 19.0% |
| Dividends Paid | -$0.84B | -$1.18B | -$1.37B | -$1.45B | -$1.59B |
| Net Stock Repurchase | -$0.02B | -$3.10B | -$3.46B | -$0.03B | $0.97B |
| Net Debt Issuance | -$6.83B | -$9.48B | $0.0B | +$5.10B | -$3.75B |
| Multiple | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| P/E Ratio | 11.7x | 4.4x | 11.4x | 14.8x | 16.9x |
| P/S Ratio | 1.04x | 1.61x | 1.87x | 1.66x | 1.86x |
| P/B Ratio | 1.33x | 1.94x | 1.76x | 1.32x | 1.11x |
| P/FCF Ratio | 3.6x | 4.7x | 8.8x | 10.2x | 9.8x |
| EV/EBITDA | 3.94x | 3.53x | 4.99x | 5.50x | 5.46x |
| EV/Sales | 2.11x | 2.15x | 2.56x | 2.58x | 2.88x |
| Dividend Yield | 3.10% | 2.03% | 2.57% | 3.21% | 3.97% |
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Return on Equity | 11.4% | 43.9% | 15.4% | 8.9% | 6.6% |
| Return on Assets | 3.1% | 18.2% | 6.3% | 3.6% | 2.7% |
| ROIC | 5.2% | 19.2% | 7.1% | 5.5% | 3.2% |
| Asset Turnover | 0.35x | 0.50x | 0.38x | 0.32x | 0.25x |
| Gross Margin | 29.3% | 47.0% | 34.4% | 35.6% | 33.8% |
| Operating Margin | 18.0% | 36.6% | 22.9% | 22.0% | 17.2% |
| Interest Coverage | 2.9x | 12.9x | 6.9x | 5.1x | 4.1x |
| Metric | FY2025A | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|---|
| Revenue (Avg) | $21.59B | $25.31B | $24.39B | $25.16B | $24.73B |
| Rev Growth | -20.3% | +17.2% | -3.6% | +3.2% | -1.7% |
| EBITDA (Avg) | $11.36B | $13.44B | $12.95B | $13.36B | $13.13B |
| EPS (Avg) | $1.61 | $4.40 | $3.67 | $3.94 | $4.02 |
| EPS Growth | -34% | +173% | -16.6% | +7.3% | +2.0% |
| # Analysts (Rev) | 7 | 7 | 7 | 6 | 5 |
| Fwd P/E | 34.2x | 12.5x | 15.0x | 14.0x | 13.7x |
| Name | Title | Type | Shares | Price | Date |
|---|---|---|---|---|---|
| Moore Jack B | director | Award | 6,720 | — | May 04 |
| Moore Jack B | director | Tax W/H | 1,479 | $60.27 | May 04 |
| Bailey Vicky A | director | Award | 3,734 | — | May 04 |
| Bailey Vicky A | director | Tax W/H | 1,223 | $60.27 | May 04 |
| Robinson Kenneth B. | director | Award | 4,149 | — | May 04 |
| Robinson Kenneth B. | director | Tax W/H | 913 | $60.27 | May 04 |
| Gould Andrew | director | Award | 4,978 | — | May 04 |
| Gould Andrew | director | Tax W/H | 1,494 | $60.27 | May 04 |
| Gutierrez Carlos M | director | Award | 3,734 | — | May 04 |
| Klesse William R | director | Award | 4,149 | — | May 04 |
| Klesse William R | director | Tax W/H | 913 | $60.27 | May 04 |
| Poladian Avedick Baruyr | director | Award | 4,149 | — | May 04 |
| Shearer Bob | director | Award | 3,734 | — | May 04 |
| Oneill Claire | director | Award | 3,734 | — | May 04 |
| Poladian Avedick Baruyr | director | Gift | 5,000 | — | Apr 14 |
| Poladian Avedick Baruyr | director | Gift | 5,000 | — | Apr 14 |
| Poladian Avedick Baruyr | director | Gift | 5,000 | — | Apr 14 |
| Poladian Avedick Baruyr | director | Gift | 5,000 | — | Apr 14 |
Q1 2026 was a clean operational beat. EPS $1.06 vs $0.65 estimate (+63%), production exceeded guidance. Per Seeking Alpha (May 6) the operational improvements are "outpacing peers" — well costs continuing to drop, recovery rates improving.
Deleveraging story has years of runway. Long-term debt down from $28.9B (FY21) to $20.4B (FY25). Berkshire preferred ($8.3B) is the next target. Each $1B retired = ~$80M annual interest savings, directly compounding FCF available for capital return.
OxyChem provides $1B+ EBITDA cushion. The chemicals segment is non-correlated with oil prices and provides downside protection. In a $50/bbl oil scenario, OxyChem alone can fund the dividend.
1Y consensus PT of $73.50 (last month, 2 brokerages) implies +33% upside. Per Seeking Alpha (May 6, "Valuation, Fundamentals Can Create Further Upside"), bull-case targets reach $130 on multiple sustained drivers including operational improvement, US energy security premium, and Berkshire warrant exercise.
Berkshire optionality. Buffett owns ~28% of OXY (common + warrants + preferred). The market continually speculates about full acquisition; even without it, the perceived "Buffett floor" provides psychological support during commodity drawdowns.
Today's -7% selloff is the warning shot. Reuters reports the Trump administration is close to an Iran peace deal, which would unlock millions of barrels per day from the Strait of Hormuz. WTI could compress 15-20% if a deal is signed; OXY's earnings power compresses ~30% on the same move.
Q1 2026 reported FCF was negative due to working capital drag (per SA "Time to Take Profits" downgrade today). The dividend + buyback program requires WTI ≥$65 for full coverage. At current $60-65 WTI, OXY runs cash-flow break-even on dividend; debt buyback gets paused.
Berkshire warrants cap upside. Buffett holds 83.9M warrants at $59 strike. As the stock approaches $59, warrant exercise becomes economically rational and creates structural overhead supply. The warrants act as a near-term ceiling around $60-62.
The "easy money trade" is behind us. Per Seeking Alpha (May 6), OXY's deleveraging narrative is largely priced in. Net debt/EBITDA at 1.93x is healthy but not exceptional. Further multiple expansion requires either oil price tailwind or surprise efficiency improvements — both uncertain.
Leadership transition. CEO Hollub has been the public face of OXY since 2016; her March 2026 announcement of operational responsibility hand-off to Richard Jackson introduces execution risk. Continuity at this scale of operations is non-trivial.
Beta of 0.17 is suspiciously low for a Permian E&P. This understates the actual stock volatility — today's -7% move on macro news demonstrates that sensitivity. Don't rely on the low-beta label for portfolio sizing.
Today's -7% move shows the magnitude of OXY's exposure to the Iran war premium. A Trump-brokered deal could unlock 2M+ bpd of supply, compressing WTI 15-20%. Earnings power compresses non-linearly — every $5/bbl move ≈ $1.5B EBITDA delta.
FY2025 EBITDA fell 11% to $11.4B as WTI averaged $70-75 vs FY22's $95+. A sustained drop to $60/bbl would compress FY26 EBITDA below $10B and force the buyback program to pause. WCS-WTI differential blowouts add asymmetric heavy-oil margin pressure.
83.9M warrants struck at $59 — economically exercisable above that level. Provides natural ceiling near current price; full exercise would add ~9% dilution. Warrant exercise pace is unpredictable and depends on Berkshire's view of the equity vs other capital deployment options.
CEO Hollub announced operational responsibility hand-off to Richard Jackson (former SVP/COO promoted to President & CFO transition). Hollub remains CEO but the operational void is being filled. Multi-year succession risk for a company that has benefited materially from Hollub's specific leadership.
CapEx at 30% of revenue is structurally heavy. Maintenance capex alone (~$5B) is required to sustain production. If FCF compresses, the dividend gets squeezed first; the buyback gets paused; debt repayment slows. Capital return is the hardest to defend in a down cycle.
OXY has invested in DAC (direct air capture) carbon technology positioning the company for an energy transition. Long-term, Permian production may face structural constraints (water, regulatory). Near-term carbon credit revenue is small. Long-tail risk; not 12-month material.
Iran tensions persist; WTI averages $80-85; Q1 operational momentum sustains. Berkshire preferred fully retired by end-2027 = $660M annualized FCF lift. Stock holds 7.5x EV/EBITDA on FY27 = ~$80. Per Reuters PT $73.50 + bull-case Seeking Alpha $130 zone.
Tracks 1Y consensus average $73.50 with discount for execution risk. WTI $70-75 supports current dividend + modest buyback. Stock holds 6x EV/EBITDA on FY26 = ~$60. Berkshire warrant exercises around $59-62 cap upside.
Iran/Hormuz deal closes; WTI compresses to $55-60. EBITDA falls to $9-10B. Buyback paused; dividend defended but barely. Stock derates to 5x EV/EBITDA = ~$40. The 200-DMA at $47 fails; FY24 low $39 retests.
This report was generated using FMP financial data as of May 6, 2026. This is for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.